Endocrinology Advisor Contributing Writer

All articles by Endocrinology Advisor Contributing Writer

Linagliptin Safe for Patients With Type 2 Diabetes and Cardiorenal Disease

By

Endocrinology Advisor Contributing Writer

June 11, 2019

Linagliptin is safe for patients with type 2 diabetes and cardiorenal disease.

Next post in Diabetes

A hemoglobin blood test

No Evidence of Legacy Effect Seen for Intensive Glucose Lowering